BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
The Key Account Manager, Solid Tumors Israel, is responsible for driving the responsible and compliant adoption of BeOne's solid tumor portfolio across assigned accounts and territories. The role develops and executes account plans, builds trusted relationships with relevant healthcare stakeholders, identifies patient-access and business opportunities, and delivers agreed commercial objectives. Working cross-functionally with Medical Affairs, Market Access, Marketing, Regulatory, Finance, and other partners, the KAM translates national strategy into high-quality local execution while keeping patients, ethics, and compliance at the center of every activity.
No direct supervisory responsibilities. The role is expected to lead through influence and coordinate effectively across cross-functional teams and external stakeholders.
Computer Skills: Proficiency in Microsoft 365 applications and experience using CRM and business-reporting tools.
Other Qualifications: Fluent Hebrew and strong business English; valid driving licence; strong communication, negotiation, analytical, planning, and presentation skills; ability to work independently and collaboratively in a fast-paced environment.
Travel: Ability to travel regularly throughout Israel and occasionally internationally, as business needs require.
Global Competencies
When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible.
To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.